Petition To US FDA For Using NMN In Supplements Reminds Agency Of Its Reversal On NAC

Natural Products Association and Alliance for Natural Health USA petition FDA to reconsider its stance on beta-nicotinamide mononucleotide. Excluding NMN from use in supplements “adversely affects the entire dietary supplement stakeholder community,” petition says.

• Source: Shutterstock

Following the playbook for reversing a US Food and Drug Administration decision on the dietary ingredient status of N-acetyl-L-cysteine, two trade associations have petitioned the agency to similarly change course on beta-nicotinamide mononucleotide.

More from Regulation

More from Policy & Regulation